📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Notices to creditors (MVL)

ASTRAZENECA INVESTMENTS LIMITED

active Company no. 02728922 Published 05 August 2026

Creditors of AstraZeneca Investments Limited must prove their debts by 28 August 2026 as required by the joint liquidators.

Notice details

Company
ASTRAZENECA INVESTMENTS LIMITED
Company number
02728922
Registered office
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA
Principal trading address
N/A
Office holder(s)/Liquidator(s)
Stephen Robert Cork; Anthony Malcolm Cork
Office holder number(s)
IP No. 8627; IP No. 009401
Date of appointment
28 July 2026
Contact
The Liquidators telephone: 0207 268 2150; Alternative contact: Irfan Sadiq Email: [email protected]

Planning a solvent wind-down or restructure?

A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.